DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing...
Үндсэн зохиолчид: | Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2010
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Is DNA testing for hypertrophic cardiomyopathy cost-effective?
-н: Wordsworth, S, зэрэг
Хэвлэсэн: (2006) -
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
-н: Wordsworth, S, зэрэг
Хэвлэсэн: (2010) -
Evaluation of Clinical Diagnostic Potential of Next Generation Sequencing using Hypertrophic Cardiomyopathy as a Model
-н: Taylor, J, зэрэг
Хэвлэсэн: (2010) -
A fast-throughput service for Familial Hypertrophic and Dilated Cardiomyopathy using High resolution melt curve analysis on the Lightscanner
-н: Thistleton, J, зэрэг
Хэвлэсэн: (2007) -
Expansion of a diagnostic service for hypertrophic cardiomyopathy using next generation sequencing
-н: Reid, S, зэрэг
Хэвлэсэн: (2011)